<DOC>
	<DOCNO>NCT02429258</DOCNO>
	<brief_summary>Effect Dapagliflozin 24-hour Blood Glucose Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin</brief_summary>
	<brief_title>Effect Dapagliflozin 24-hour Blood Glucose T2DM Patients Inadequately Controlled With Either Metformin Or Insulin</brief_title>
	<detailed_description>Effect Dapagliflozin 24-hour Blood Glucose 92 Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes mellitus ( T2DM ) Treated either stable dose metformin alone &gt; = 1500mg/day stable dose insulin &gt; = 30 units/day 2OAD medication least 8 week Hemoglobin A1c ( HbA1c ) 7.5 % 10.5 % screen Body mass index ( BMI ) &lt; = 45 kg/m2 For patient enter study take stable dose metformin , history take OAD medication metformin 8 week prior screen insulin therapy within 1 year screening For patient enter study take insulin , history take therapy outside stable insulin 2 OAD medication 8 week prior screen . Use sulfonylureas 8 week prior screen Prior exposure dapagliflozin sodiumglucose cotransporter 2 ( SGLT2 ) inhibitor Ingestion medication know affect glucose metabolism &gt; 7 consecutive day 3 month prior Screening Ingestion prescription counter weight loss medication 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>